Evidence map›Paper›PMID 27575985›Full record

ArticleMatrix biology : journal of the International Society for Matrix Biology2017

A step towards clinical application of acellular matrix: A clue from macrophage polarization.

Astgik Petrosyan, Stefano Da Sacco, Nikita Tripuraneni, Ursula Kreuser, Maria Lavarreda-Pearce, Riccardo Tamburrini, Roger E De Filippo, Giuseppe Orlando, Paolo Cravedi, Laura Perin

Open access · greenAbstract read
In one paragraph

Article in Matrix biology : journal of the International Society for Matrix Biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Recruited CD68Bioactive materials · 2021
    Article
  13. Article
  14. Exosomal αvβ6 integrin is required for monocyte M2 polarization in prostate cancer.Matrix biology : journal of the International Society for Matrix Biology · 2018
    Article
  15. Regenerative immunology: the immunological reaction to biomaterials.Transplant international : official journal of the European Society for Organ Transplantation · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Astgik PetrosyanGOFARR Laboratory for Organ Regenerative Research and Cell Therapeutics, Saban Research Institute, Children's Hospital Los Angeles, Department of Urology, University of Southern California, Los Angeles, CA 90027, USA.
Stefano Da SaccoGOFARR Laboratory for Organ Regenerative Research and Cell Therapeutics, Saban Research Institute, Children's Hospital Los Angeles, Department of Urology, University of Southern California, Los Angeles, CA 90027, USA.
Nikita TripuraneniGOFARR Laboratory for Organ Regenerative Research and Cell Therapeutics, Saban Research Institute, Children's Hospital Los Angeles, Department of Urology, University of Southern California, Los Angeles, CA 90027, USA.
Ursula KreuserRadboud Institute for Molecular Life Sciences, Department of Physiology, 6525 GA Nijmegen, The Netherlands.
Maria Lavarreda-PearceGOFARR Laboratory for Organ Regenerative Research and Cell Therapeutics, Saban Research Institute, Children's Hospital Los Angeles, Department of Urology, University of Southern California, Los Angeles, CA 90027, USA.
Riccardo TamburriniDepartment of General Surgery, Section of Transplantation, Wake Forest School of Medicine, Winston Salem, NC 27157, USA.
Roger E De FilippoGOFARR Laboratory for Organ Regenerative Research and Cell Therapeutics, Saban Research Institute, Children's Hospital Los Angeles, Department of Urology, University of Southern California, Los Angeles, CA 90027, USA.
Giuseppe OrlandoDepartment of General Surgery, Section of Transplantation, Wake Forest School of Medicine, Winston Salem, NC 27157, USA.
Paolo CravediRenal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, Annenberg Building, New York, NY 10029, USA.
Laura PerinGOFARR Laboratory for Organ Regenerative Research and Cell Therapeutics, Saban Research Institute, Children's Hospital Los Angeles, Department of Urology, University of Southern California, Los Angeles, CA 90027, USA. Electronic address: lperin@chla.usc.edu.
University of Southern California · USWake Forest University · USIcahn School of Medicine at Mount Sinai · USRadboud University Nijmegen · NL

Funding

Translational Immunology Training ProgramT32AI078892 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Karen Leigh Edelblum, SERGIO A. LIRA · 2008 to 2026
$4.5M
NIAID NIH HHS T32 AI078892
6 · The paper itself

Abstract

The outcome of tissue engineered organ transplants depends on the capacity of the biomaterial to promote a pro-healing response once implanted in vivo. Multiple studies, including ours, have demonstrated the possibility of using the extracellular matrix (ECM) of animal organs as platform for tissue engineering and more recently, discarded human organs have also been proposed as scaffold source. In contrast to artificial biomaterials, natural ECM has the advantage of undergoing continuous remodeling which allows adaptation to diverse conditions. It is known that natural matrices present diverse immune properties when compared to artificial biomaterials. However, how these properties compare between diseased and healthy ECM and artificial scaffolds has not yet been defined. To answer this question, we used decellularized renal ECM derived from WT mice and from mice affected by Alport Syndrome at different time-points of disease progression as a model of renal failure with extensive fibrosis. We characterized the morphology and composition of these ECMs and compared their in vitro effects on macrophage activation with that of synthetic scaffolds commonly used in the clinic (collagen type I and poly-L-(lactic) acid, PLLA). We showed that ECM derived from Alport kidneys differed in fibrous protein deposition and cytokine content when compared to ECM derived from WT kidneys. Yet, both WT and Alport renal ECM induced macrophage differentiation mainly towards a reparative (M2) phenotype, while artificial biomaterials towards an inflammatory (M1) phenotype. Anti-inflammatory properties of natural ECMs were lost when homogenized, hence three-dimensional structure of ECM seems crucial for generating an anti-inflammatory response. Together, these data support the notion that natural ECM, even if derived from diseased kidneys promote a M2 protolerogenic macrophage polarization, thus providing novel insights on the applicability of ECM obtained from discarded organs as ideal scaffold for tissue engineering.

Indexed as

AnimalsAnti-Inflammatory AgentsCollagen Type ICytokinesDisease Models, AnimalExtracellular MatrixHumansImmunohistochemistryImmunophenotypingKidneyMacrophage ActivationMacrophagesMiceMice, Inbred C57BLNephritis, HereditaryPhenotypeAnti-Inflammatory AgentsCollagen Type ICytokinesPolyesterspoly(lactide)Cell–matrix interactionsMacrophagesRenal extracellular matrix scaffolds (ECM)

Identifiers

PMID27575985
PMCPMC6717660
OpenAlexW2515444928

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.